Literature DB >> 26187339

Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder.

Naren P Rao1, Ganesan Venkatasubramanian2, Vasanthapuram Ravi3, Sunil Kalmady2, Anish Cherian2, Janardhan Reddy Yc2.   

Abstract

Growing evidence in the last decade suggest significant role of immune alterations in the pathogenesis of obsessive-compulsive disorder (OCD). Cytokines, mediators of inflammation, alter the neurotransmitter concentration and result in a hyposerotonergic and hyperglutamatergic state implicated in pathogenesis of OCD. However, only few studies have examined cytokine abnormalities in OCD with inconsistent results possibly due to confounding effects of medications and comorbid anxiety-depression. We examined 20 comorbidity free, drug free OCD patients and 20 age and sex matched healthy controls. Clinical severity was assessed using Yale Brown Obsessive Compulsive Scale, Hamilton anxiety rating scale, Hamilton depression rating scale and Clinical Global Impression. Levels of different cytokines, Interleukin (IL)-2, IL-4, IL-6, IL-10, Tumor necrosis factor (TNF)-α and Interferon (IFN)-γ were assessed using Cytometric Bead Array. OCD patients had significantly greater plasma levels of IL-2, IL-4, IL-6, IL-10 and TNF-α levels than controls but not IFN-γ. Reanalysis of data with only drug naïve patients (excluding 4 drug free patients) did not alter the results. Presence of these abnormalities in drug-naïve patients suggests the possible role of cytokines in the pathogenesis of OCD. Study findings have potential clinical utility in development of novel therapeutic options targeting cytokine aberrations in OCD.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Glutamate; Inflammation; Kynurenine; OCD; Serotonin

Mesh:

Substances:

Year:  2015        PMID: 26187339     DOI: 10.1016/j.psychres.2015.07.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  25 in total

Review 1.  Obsessive-Compulsive Disorder: Autoimmunity and Neuroinflammation.

Authors:  Mona Gerentes; Antoine Pelissolo; Krishnamoorthy Rajagopal; Ryad Tamouza; Nora Hamdani
Journal:  Curr Psychiatry Rep       Date:  2019-08-01       Impact factor: 5.285

2.  Immunoglobulin A Dysgammaglobulinemia Is Associated with Pediatric-Onset Obsessive-Compulsive Disorder.

Authors:  Kyle Williams; Leah Shorser-Gentile; Suraj Sarvode Mothi; Noah Berman; Mark Pasternack; Daniel Geller; Jolan Walter
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-03-20       Impact factor: 2.576

Review 3.  Role of Sonic Hedgehog Signaling Activation in the Prevention of Neurological Abnormalities Associated with Obsessive-Compulsive Disorder.

Authors:  Ria Gupta; Sidharth Mehan; Swesha Chhabra; Aditi Giri; Kajal Sherawat
Journal:  Neurotox Res       Date:  2022-10-22       Impact factor: 3.978

4.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

5.  Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis.

Authors:  Theodore D Cosco; Toby Pillinger; Hadeer Emam; Marco Solmi; Sanjay Budhdeo; A Matthew Prina; Michael Maes; Dan J Stein; Brendon Stubbs; Andre F Carvalho
Journal:  Mol Neurobiol       Date:  2018-10-31       Impact factor: 5.590

Review 6.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

7.  Changes of Nitric Oxide and Peroxynitrite Serum Levels during Drug Therapy in Patients with Obsessive-Compulsive Disorder.

Authors:  Leila Kouti; Mehdi Sayyah; Parisa Mosallanezhad; Sara Kooti; Maryam Aghakoochakzadeh; Kaveh Eslami
Journal:  Adv Med       Date:  2016-10-16

8.  Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.

Authors:  Natalia Rodríguez; Astrid Morer; E Azucena González-Navarro; Carles Serra-Pages; Daniel Boloc; Teresa Torres; Susana García-Cerro; Sergi Mas; Patricia Gassó; Luisa Lázaro
Journal:  J Neuroinflammation       Date:  2017-12-28       Impact factor: 8.322

9.  Increased Risk of Sjögren's Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study.

Authors:  Yi-Jung Chang; Jui-Cheng Tseng; Pui-Ying Leong; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  Int J Environ Res Public Health       Date:  2021-06-01       Impact factor: 3.390

10.  Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.

Authors:  Hidehiro Umehara; Shusuke Numata; Atsushi Tajima; Akira Nishi; Masahito Nakataki; Issei Imoto; Satsuki Sumitani; Tetsuro Ohmori
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.